Erratum  by unknown
ERRATA
In ‘‘Role of Antithymocyte Globulin and Granulocyte-Colony Stimulating Factor-Mobilized Bone Marrow
in Allogeneic Transplantation for Patients with Hematologic Malignancies’’ (Chen et al, Biol Blood Marrow
Transplant 2009:15:266-273) there was an error in the first paragraph of the ‘‘Conditioning Regimen’’ subsection
of the ‘‘Patients and Methods’’ section. In the last sentence of this paragraph, the drug used was ATG-Fresenius,
not ThymoglobulineTM. The corrected sentence is as follows: All patients received ATG-Fresenius (5 mg/kg per
day; Fresenius, Germany) intravenously for 4 consecutive days, on days25 to22.In the poster #280 titled, ‘‘Pre-emptive Treatment with Cidofovir for Symptomatic BK Virus Positive
Patients Who Underwent Allogeneic Stem Cell Transplant Reduces the Risk of Progression to Hemorrhagic
Cystitis’’ (Bilodeau et al, Biol Blood Marrow Transplant 2009;15/2S:102) there was a dosing error in the second
column, line 13. ‘‘. subsequently received Cidofovir 375 mg i.v. QOW.’’ is corrected as follows, ‘‘. sub-
sequently received Cidofovir 0.2 mg/kg i.v. QOW.’’.
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